Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Randomised controlled trial of surveillance and no surveillance for patients with Barrett's oesophagus: BOSS (Barrett's Oesophagus Surveillance Study)
Source of recordUK Trials
ISRCTNISRCTN54190466
Date ISRCTN assigned08/01/2008
Local reference number(s)HTA 05/12/01
Public titleRandomised controlled trial of surveillance and no surveillance for patients with Barrett's oesophagus: BOSS (Barrett's Oesophagus Surveillance Study)
Scientific title
AcronymBOSS
Disease/condition/study domainBarrett's oesophagus
Study hypothesisComparison of endoscopic surveillance verus no endoscopic surveillance for the prevention of early mortality and the development of oesophageal adenocarcinoma.
Design/methodologyRandomised controlled trial
Research ethics reviewSubmission pending as of 2nd January 2008
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients over 18 with endoscopic and histologically proven barrett's oesophagus greater than 1 cm
Participants - exclusion criteria1. Unable to give consent
2. Unable to tolerate upper gastrointestinal endoscopy
Patient information materialNot available in web format, please use the contact details below to request a patient information sheet
Anticipated start date01/09/2008
Anticipated end date01/09/2021
Status of trialOngoing
Target number of participants2,500
InterventionsUpper gastrointestinalendoscopy every 2 years for 10 years
Primary outcome measure(s)1. All causes mortality
2. Death from adenocarcinoma
3. Development of treatable adenocarcinoma

Duration of follow-up: 10 years
Secondary outcome measure(s)1. Quality of life: Reflux Questionnaire and EQ50 Quality of Life Questionnaire at yearly intervals by post
2. Cost effectiveness of endoscopy
Sources of fundingNIHR Health Technology Assessment Programme - HTA (UK)
Sponsor nameGloucestershire Royal NHS Foundation Trust (UK)
Sponsor detailsResearch and Development Support Unit
Great western Road
Gloucester
United Kingdom
GL1 3NN
Sponsor telephone+44 (0)8454 226679
Sponsor fax+44 (0)8454 226813
Sponsor emailhugh.barr@glos.nhs.uk
Contact nameProf Hugh Barr
Contact detailsGloucestershire Royal Hospital
Great Western Road
Gloucester
United Kingdom
GL1 3NN
Contact emailhugh.barr@glos.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN54190466
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central